Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @WatchlistN | 10 |
| @TranscriptDaily | 7 |
| @TickerReport | 6 |
| @ConsumerFeed | 5 |
| @OlympiaReport | 5 |
Recent Tweets for MYGN
 |
@dakotafinancial Myriad Genetics $MYGN Expected to Post Quarterly Sales of $195.76 Million https://t.co/EmqzmsSrsd May 25th 2018, 8:05am |
 |
@TheMarketsDaily Zacks: Analysts Anticipate Myriad Genetics $MYGN Will Post Quarterly Sales of $195.76 Million https://t.co/UKbLj4k4rc May 25th 2018, 8:05am |
 |
@WatchlistN Head-To-Head Comparison: Myriad Genetics $MYGN and Ipsen $IPSEY https://t.co/C2YsgQmENd May 24th 2018, 1:05pm |
 |
@ledgerzette Financial Survey: Myriad Genetics $MYGN and Ipsen $IPSEY https://t.co/EEVMpXqLOc May 24th 2018, 1:05pm |
 |
@WeekHerald Head-To-Head Comparison: Myriad Genetics $MYGN vs. Vermillion $VRML https://t.co/z0xrGyg4YM May 24th 2018, 12:05pm |
 |
@dispatchtribune Critical Comparison: Myriad Genetics $MYGN vs. Vermillion $VRML https://t.co/iL9CWFc2ze May 24th 2018, 11:05am |
|
@WatchlistN Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/xGu3XbiYT7 May 24th 2018, 7:05am |
 |
@TickerReport Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/PsnTcaSX23 May 24th 2018, 7:05am |
 |
@MarketCurrents Seven new payers sign on to cover Myriad's Prolaris https://t.co/sI3B4vgtGw $MYGN May 23rd 2018, 4:05pm |
 |
@GNWLive Myriad Announces Seven New Payer Coverage Decisions for Prolaris® $MYGN https://t.co/Lo9gUYe7k2 May 23rd 2018, 4:05pm |
 |
@stockelite $MYGN Myriad Announces Seven New Payer Coverage Decisions for Prolaris® https://t.co/u3cVGuLBF8 May 23rd 2018, 4:05pm |
 |
@StockTexts $MYGN Myriad Announces Seven New Payer Coverage Decisions for Prolaris® Nasdaq:MYGN https://t.co/kdOgYANzQR May 23rd 2018, 4:05pm |
 |
@UsefulArts After glowing WSJ article about $MYGN helping #depression treatment, Dr. @EricTopol says look for proof. cc:… https://t.co/ATvrkSJHgo May 23rd 2018, 3:05pm |
 |
@ThisLincolnian Analysts Anticipate Myriad Genetics $MYGN Will Announce Earnings of $0.33 Per Share https://t.co/pjX1dQejNs May 23rd 2018, 6:05am |
 |
@TranscriptDaily Dennis Langer Sells 10,000 Shares of Myriad Genetics $MYGN Stock https://t.co/W53iA2fkuc May 23rd 2018, 5:05am |
 |
@OlympiaReport Myriad Genetics $MYGN Director Sells $359,000.00 in Stock https://t.co/CFyn5KyuuM May 23rd 2018, 5:05am |
|
@TranscriptDaily Zacks: Brokerages Anticipate Myriad Genetics $MYGN to Announce $0.33 Earnings Per Share https://t.co/dJSz4jSkXy May 23rd 2018, 1:05am |
|
@WatchlistN Myriad Genetics $MYGN Receives $31.17 Average PT from Brokerages https://t.co/cxchn3btJ5 May 22nd 2018, 4:05pm |
 |
@ConsumerFeed Comparing Vermillion $VRML and Myriad Genetics $MYGN https://t.co/22sF3CSiVA May 22nd 2018, 2:05pm |
 |
@ResearchPool $MYGN #Myriad Genetics Inc. Myriads high-quality genetic tests support a narrow moat and expanding reimbursement.:… https://t.co/RHXiXg3D8Q May 22nd 2018, 10:05am |
|
@ledgerzette Myriad Genetics $MYGN Director Dennis Langer Sells 10,000 Shares https://t.co/JInScXGQXz May 22nd 2018, 6:05am |
|
@TickerReport Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/vIFSVjlVKk May 22nd 2018, 3:05am |
|
@WatchlistN Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/OxHq8anf8i May 22nd 2018, 3:05am |
|
@TickerReport Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/WhKWKWkixB May 22nd 2018, 3:05am |
|
@ConsumerFeed Myriad Genetics Director Dennis Langer Sells $359,000.00 in $MYGN https://t.co/IrFMW44HuR May 22nd 2018, 3:05am |
 |
@AmericanBanking Insider Selling: Myriad Genetics $MYGN Director Sells 10,000 Shares of Stock https://t.co/KVteOkdvvr #stocks May 21st 2018, 10:05pm |
|
@dispatchtribune Dennis Langer Sells 10,000 Shares of Myriad Genetics $MYGN Stock https://t.co/yYp6G0EZ9h May 21st 2018, 10:05pm |
 |
@InsiderAlertsIA $MYGN: New Insider Filing on Director DENNIS LANGER: https://t.co/CLU5jV61Bf May 21st 2018, 8:05pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/zkXy89dxxE May 21st 2018, 8:05pm |
 |
@confcalltran Myriad Genetics director just cashed-in 10,000 options https://t.co/M1jA7gVvvU $MYGN May 21st 2018, 8:05pm |
 |
@ChartMill Looking at the yearly performance, $MYGN did better than 90% of all other stocks. https://t.co/Vz4voen3yA https://t.co/74ETeSbGWo May 21st 2018, 1:05pm |
|
@dakotafinancial Zacks Investment Research Downgrades Myriad Genetics $MYGN to Hold https://t.co/K6X7SsZM0w May 21st 2018, 5:05am |
|
@WeekHerald Brokerages Set Myriad Genetics $MYGN PT at $31.17 https://t.co/yzgYaEIrZd May 20th 2018, 1:05pm |
|
@TranscriptDaily Myriad Genetics $MYGN Downgraded by Zacks Investment Research to Hold https://t.co/QEiDR30QKA May 20th 2018, 4:05am |
|
@TheMarketsDaily Myriad Genetics $MYGN Rating Lowered to Hold at Zacks Investment Research https://t.co/XfFxiTANf9 May 20th 2018, 4:05am |
|
@OlympiaReport Analyzing Vermillion $VRML & Myriad Genetics $MYGN https://t.co/pHJ7qoawYl May 20th 2018, 2:05am |
 |
@registrarjourn Myriad Genetics $MYGN Downgraded to “Hold” at Zacks Investment Research https://t.co/1SaHWlJxew May 19th 2018, 11:05am |
|
@AmericanBanking Myriad Genetics $MYGN Lowered to Hold at Zacks Investment Research https://t.co/SOIOQgMWHH #stocks May 18th 2018, 4:05pm |
 |
@dailypoliticaln Comparing Myriad Genetics $MYGN and BG Medicine $BGMD https://t.co/ldvyHC8soq May 18th 2018, 4:05pm |
|
@registrarjourn Comparing Myriad Genetics $MYGN and BG Medicine $BGMD https://t.co/pOsNUFXk91 May 18th 2018, 2:05pm |
|
@WeekHerald Zacks Investment Research Lowers Myriad Genetics $MYGN to Hold https://t.co/NOngDSsEpH May 18th 2018, 1:05pm |
|
@ConsumerFeed Zacks Investment Research Lowers Myriad Genetics $MYGN to Hold https://t.co/bASkZKrzaf May 18th 2018, 1:05pm |
|
@WatchlistN Head to Head Review: Vermillion $VRML vs. Myriad Genetics $MYGN https://t.co/Tt8bBtnVbI May 17th 2018, 3:05pm |
|
@ledgerzette Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/yVpStID2Ko May 17th 2018, 6:05am |
|
@dakotafinancial Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/d1QfK7Afm8 May 17th 2018, 5:05am |
|
@TheMarketsDaily Myriad Genetics $MYGN Given Average Recommendation of “Hold” by Brokerages https://t.co/55e89ZCEq2 May 17th 2018, 5:05am |
|
@AmericanBanking Myriad Genetics $MYGN Given Average Rating of “Hold” by Analysts https://t.co/Kuez5j1THy #stocks May 17th 2018, 5:05am |
|
@dispatchtribune Myriad Genetics Expected to Earn FY2018 Earnings of $1.21 Per Share $MYGN https://t.co/2VgYSUMAJ6 May 16th 2018, 3:05am |
|
@OlympiaReport Myriad Genetics Expected to Earn FY2018 Earnings of $1.21 Per Share $MYGN https://t.co/YumpEBs3tu May 16th 2018, 3:05am |
 |
@pennyomegaCRWE $MYGN to reveal findings from eight studies in patients with cancer https://t.co/jwJxDPhGlF May 15th 2018, 10:05am |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.